AARP has taken over $4.5 billion from health insurance companies and is now actively working to persuade lawmakers to support government price controls in Medicare Part D. This will financially benefit health insurance companies but fail to lower the prices most seniors pay for their prescription drugs at the pharmacy counter. Urge the Senate to oppose special interests and to NOT raid Medicare Part D.
You also might be interested in
Tax Reform Passage a Tremendous Win for America’s Workers & Consumers[...]
For most Americans, being hospitalized is a rare and frightening[...]
CASE Op-Ed: Sue Here, Sue Now – How the Left’s Deranged Climate Change Lawsuits Will Make Us All Pay
Gerard Scimeca – Chairman, CASE February 27 – http://bit.ly/2HMTNT4 In case[...]
Search
Categories
- Aegis
- Agriculture
- Commerce
- Communications
- Consumer Safety
- Data Privacy
- Economy
- Education
- Energy
- Entertainment
- Environment
- Financial Services
- Fiscal Policy
- Healthcare
- Higher Ed on the Hill
- Intellectual Property
- Kentucky
- Labor
- Legal
- Lifestyle
- Manufacturing
- Media
- Regulation
- Retail
- Robotexts
- Taxes
- TCPA
- Technology
- Trade
- Transportation
- Uncategorized
- Veterans
Archives
Contact Us
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/